NCT04868175View on ClinicalTrials.gov

Interval Intraocular Pressure in Intravitreal Injection Study

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

April 1, 2021

Conditions
GlaucomaIntraocular Pressure
Interventions
DRUG

Timolol

Topical eye drops for lowering intraocular pressure Beta blocker to reduce aqueous production

DRUG

Travatan

Topical eye drops for lowering intraocular pressure Prostaglandin analogue to increase aqueous outflow

DRUG

Hypromellose

Placebo eye drop, lubricant

Trial Locations (1)

000000

HKSDS Program, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT04868175 - Interval Intraocular Pressure in Intravitreal Injection Study | Biotech Hunter | Biotech Hunter